🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with france ansm? Page 2

Has anyone dealt with france ansm?

mia_MS2 Wed, Jul 2, 2025 at 6:21 PM 27 replies 1,773 viewsPage 2 of 6
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Jul 2, 2025 at 9:29 PM#6

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

12 7stefan_berlin, Dr.EM_Chicago, pete_RVA and 9 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Jul 2, 2025 at 10:42 PM#7

Following on from carl_compliance — and this may be the naive question:

What would you measure differently if you were starting again?

11 6Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 8 others
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Jul 2, 2025 at 11:55 PM#8
lisa_labSD said:
One practical note: write down what you did and when, before you need it.

There is a second half to this that has not been said yet. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

10 5amsterdam_pete, LondonLisa, mike_nyc and 7 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Jul 3, 2025 at 1:08 AM#9

Closing the loop on my own question.

Update — I was wrong in the opening post, specifically about the direction. Correcting it here rather than editing it away.

Last edited: Jul 3, 2025 at 4:08 AM
9 4steve_okc, dave_SLC, FDA_TrackerJim and 6 others
Reply Quote Save Share Report
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Jul 3, 2025 at 7:01 AM#10
LindaRN_retired said:
The version of this that has an answer is narrower than the version being asked.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

49 24TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 46 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register